Adverum Historical Valuation

ADVM Stock

USD 0.73 0.07 8.75%

Some fundamental drivers such as market cap or Adverum Biotechnologies enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Adverum Biotechnologies valuation indicators such as Average Assets of 595 M or Average Equity of 342 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Adverum Biotechnologies's future value. Financial Statement Analysis is much more than just reviewing and breaking down Adverum Biotechnologies prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Adverum Biotechnologies is a good buy for the upcoming year.

Check out Trending Equities. To learn how to invest in Adverum Stock please use our How to Invest in Adverum Biotechnologies guide.

Working Capital Average Assets

About Adverum Valuation Data Analysis

Valuation is the financial process of determining what Adverum Biotechnologies is worth. Adverum Biotechnologies valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Adverum Biotechnologies valuation ratios help investors to determine whether Adverum Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Adverum with respect to the benefits of owning Adverum Biotechnologies security.

Adverum Biotechnologies Valuation Data Chart

Adverum valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Adverum equity instrument and the benefits of owning shares of Adverum Biotechnologies.

Adverum Biotechnologies Average Assets are very stable at the moment as compared to the past year. Adverum Biotechnologies reported last year Average Assets of 551.43 Million. As of 30th of March 2023, Enterprise Value is likely to grow to about 377.3 M, while Revenue Per Employee is likely to drop about 38.4 K.

Average Assets Enterprise Value Market Capitalization

Add Fundamental

Average Assets

Average asset value for the period used in calculation of Return on Average Equity and Return on Average Assets; derived from Total Assets.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Adverum Biotechnologies theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Adverum Biotechnologies debt, but would also pocket its cash. Enterprise Value is more accurate representation of Adverum Biotechnologies value than its market capitalization because it takes into account all of Adverum Biotechnologies existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Adverum Biotechnologies. It is equal to Adverum Biotechnologies current share price times the number of Adverum Biotechnologies outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].

Most indicators from Adverum Biotechnologies' valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Adverum Biotechnologies current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities. To learn how to invest in Adverum Stock please use our How to Invest in Adverum Biotechnologies guide.Adverum Biotechnologies Average Assets are very stable at the moment as compared to the past year. Adverum Biotechnologies reported last year Average Assets of 551.43 Million. As of 30th of March 2023, Enterprise Value is likely to grow to about 377.3 M, while Revenue Per Employee is likely to drop about 38.4 K.

	2020	2021	2022	2023 (projected)
Tangible Asset Value	482.57 M	439.73 M	505.69 M	545.61 M
Market Capitalization	1.06 B	172.75 M	155.47 M	159.56 M

Tangible Asset Value Market Capitalization

Adverum Biotechnologies valuation accounts Correlations

	Net Income Per Employee	Revenue Per Employee	Average Assets	Earnings before Tax	Average Equity	Enterprise Value	Free Cash Flow	Invested Capital	Invested Capital Average	Market Capitalization	Tangible Asset Value	Working Capital
Net Income Per Employee		-0.02	-0.5	0.66	-0.57	0.79	0.4	-0.18	-0.2	0.73	-0.46	-0.53
Revenue Per Employee	-0.02		0.35	-0.23	0.32	-0.05	-0.27	0.44	0.46	-0.13	0.31	0.24
Average Assets	-0.5	0.35		-0.95	0.96	-0.55	-0.96	0.91	0.92	-0.72	0.99	0.91
Earnings before Tax	0.66	-0.23	-0.95		-0.94	0.61	0.94	-0.83	-0.82	0.74	-0.93	-0.89
Average Equity	-0.57	0.32	0.96	-0.94		-0.63	-0.93	0.82	0.82	-0.75	0.96	0.97
Enterprise Value	0.79	-0.05	-0.55	0.61	-0.63		0.49	-0.22	-0.28	0.96	-0.47	-0.53
Free Cash Flow	0.4	-0.27	-0.96	0.94	-0.93	0.49		-0.93	-0.92	0.68	-0.95	-0.86
Invested Capital	-0.18	0.44	0.91	-0.83	0.82	-0.22	-0.93		0.99	-0.45	0.91	0.75
Invested Capital Average	-0.2	0.46	0.92	-0.82	0.82	-0.28	-0.92	0.99		-0.52	0.9	0.74
Market Capitalization	0.73	-0.13	-0.72	0.74	-0.75	0.96	0.68	-0.45	-0.52		-0.64	-0.63
Tangible Asset Value	-0.46	0.31	0.99	-0.93	0.96	-0.47	-0.95	0.91	0.9	-0.64		0.95
Working Capital	-0.53	0.24	0.91	-0.89	0.97	-0.53	-0.86	0.75	0.74	-0.63	0.95

Click cells to compare fundamentals

Adverum Biotechnologies Account Relationship Matchups

Adverum Biotechnologies valuation accounts Accounts

	2018	2019	2020	2021	2022	2023 (projected)
Net Income Per Employee	(885.7 K)	(565.67 K)	(701.71 K)	(774.15 K)	(890.27 K)	(960.56 K)
Revenue Per Employee	23.7 K	19.66 K	2.19 K	39.89 K	45.88 K	38.44 K
Average Assets	235.79 M	214.8 M	417.51 M	479.5 M	551.43 M	594.96 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	(72.13 M)	(62.91 M)	(112.23 M)	(140.9 M)	(126.81 M)	(130.14 M)
Earnings Before Interest Taxes and Depreciation Amortization USD	(72.13 M)	(62.91 M)	(112.23 M)	(140.9 M)	(126.81 M)	(130.14 M)
Earnings before Tax	(73.88 M)	(64.49 M)	(116.39 M)	(145.54 M)	(130.99 M)	(134.43 M)
Average Equity	224.05 M	176.26 M	371.39 M	364.04 M	418.64 M	341.99 M
Enterprise Value	37.36 M	693.26 M	1.01 B	252.63 M	290.53 M	377.34 M
Free Cash Flow	(54.77 M)	(68.42 M)	(91.14 M)	(122.95 M)	(110.66 M)	(113.57 M)
Invested Capital	46.83 M	164.64 M	424.51 M	482.82 M	555.24 M	599.07 M
Invested Capital Average	66.48 M	127.94 M	351.6 M	505.87 M	581.75 M	627.68 M
Market Capitalization	198.04 M	744.05 M	1.06 B	172.75 M	155.47 M	159.56 M
Tangible Asset Value	213.5 M	222.73 M	482.57 M	439.73 M	505.69 M	545.61 M
Working Capital	198.03 M	156.46 M	413.57 M	295.82 M	340.2 M	287.36 M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.

Pair Trading with Adverum Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Adverum Biotechnologies

-	0.75	VCNX	Vaccinex		Pair Corr
-	0.71	A	Agilent Technologies	Fiscal Quarter End 30th of April 2023	Pair Corr
-	0.7	MNKD	MannKind Corp	Fiscal Quarter End 31st of March 2023	Pair Corr
-	0.66	EQ	Equillium	Fiscal Quarter End 31st of March 2023	Pair Corr
-	0.66	DNLI	Denali Therapeutics	Fiscal Quarter End 31st of March 2023	Pair Corr

The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.

The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Trending Equities. To learn how to invest in Adverum Stock please use our How to Invest in Adverum Biotechnologies guide. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for analysis

When running Adverum Biotechnologies price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.

	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.69)

Quarterly Revenue Growth

(0.70)

Return On Assets

(0.23)

Return On Equity

(0.56)

The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Adverum Biotechnologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Adverum Historical Valuation

About Adverum Valuation Data Analysis

Adverum Biotechnologies Valuation Data Chart

Average Assets

Enterprise Value

Market Capitalization

Adverum Biotechnologies valuation accounts Correlations

Adverum Biotechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Adverum Biotechnologies valuation accounts Accounts

Pair Trading with Adverum Biotechnologies

Moving against Adverum Biotechnologies

Complementary Tools for analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Tangible Asset Value	+ 0.99	Average Assets
Invested Capital Average	+ 0.99	Invested Capital
Working Capital	+ 0.97	Average Equity
Average Equity	+ 0.96	Average Assets
Tangible Asset Value	+ 0.96	Average Equity
Market Capitalization	+ 0.96	Enterprise Value

Free Cash Flow	- 0.96	Average Assets
Tangible Asset Value	- 0.95	Free Cash Flow
Earnings before Tax	- 0.95	Average Assets
Average Equity	- 0.94	Earnings before Tax
Invested Capital	- 0.93	Free Cash Flow
Free Cash Flow	- 0.93	Average Equity